hexamethonium has been researched along with Cardiovascular Diseases in 4 studies
Hexamethonium: A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool.
Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.
Excerpt | Relevance | Reference |
---|---|---|
"Lead is considered a causative factor for hypertension and other cardiovascular diseases." | 3.85 | Sub-chronic lead exposure produces β ( Alonso, MJ; Fioresi, M; Salaices, M; Simões, MR; Toscano, CM; Vassallo, DV, 2017) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Toscano, CM | 1 |
Simões, MR | 1 |
Alonso, MJ | 1 |
Salaices, M | 1 |
Vassallo, DV | 1 |
Fioresi, M | 1 |
Gulliford, M | 1 |
Charlton, J | 1 |
Bhattarai, N | 1 |
Rudisill, C | 1 |
PACIFICO, A | 1 |
AUBERT, H | 1 |
GAVRILESCU, S | 1 |
4 other studies available for hexamethonium and Cardiovascular Diseases
Article | Year |
---|---|
Sub-chronic lead exposure produces β
Topics: Animals; Arterial Pressure; Cardiovascular Diseases; Down-Regulation; Heart Rate; Hexamethonium; Hyp | 2017 |
Social and material deprivation and the cost-effectiveness of an intervention to promote physical activity: cohort study and Markov model.
Topics: Adult; Cardiovascular Diseases; Chronic Disease; Cohort Studies; Cost-Benefit Analysis; Cultural Dep | 2014 |
[Limitations and possibilities of hexamethonium in cardiovascular pathology].
Topics: Cardiovascular Agents; Cardiovascular Diseases; Coronary Disease; Hexamethonium; Humans; Muscle Rela | 1956 |
[Hexamethonium bromide in therapy of some cardiovascular diseases].
Topics: Cardiovascular Diseases; Hexamethonium; Hexamethonium Compounds; Humans | 1956 |